Coeptis Therapeutics Inc.

NASDAQ: COEP · Real-Time Price · USD
13.96
2.48 (21.60%)
At close: Aug 15, 2025, 3:59 PM
13.81
-1.11%
After-hours: Aug 15, 2025, 06:35 PM EDT

Coeptis Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a 75K
Cost of Revenue
1.04M 1M 1M n/a
Gross Profit
-1.04M -1M -1M -372K
Operating Income
-10.05M -21.49M -34.2M -14.05M
Interest Income
n/a n/a n/a n/a
Pretax Income
-10.88M -21.27M -37.57M -13.45M
Net Income
-9.81M -21.27M -37.57M -13.45M
Selling & General & Admin
945.64K 13.82M 33.17M 14.12M
Research & Development
2.33M 6.67M 20.89K n/a
Other Expenses
6.78M n/a n/a n/a
Operating Expenses
10.05M 20.49M 33.2M 14.12M
Interest Expense
n/a -108K 218.41K 187.13K
Selling & Marketing Expenses
n/a 12.71K 8.33K 2.92K
Cost & Expenses
-10.05M 21.49M 34.2M 14.12M
Income Tax Expense
-1.06M n/a n/a n/a
Shares Outstanding (Basic)
1.93M 25.69M 14.3M 1.02M
Shares Outstanding (Diluted)
1.93M 25.69M 14.3M 1.02M
EPS (Basic)
-5.1 -0.83 -2.87 -13.16
EPS (Diluted)
-5.1 -0.83 -2.87 -13.16
EBITDA
-10.05M -20.16M -36.35M -12.81M
EBIT
-11.27M -21.16M -37.36M -13.26M
Depreciation & Amortization
1.04M 1M 1M 447.41K